test

Prompt

Act as a skeptical, creative global deep-value equity investor. Find overlooked public companies where the current share price is substantially below conservatively estimated intrinsic value, permanent capital impairment appears manageable, and identifiable actions could unlock value. The central question is: “What am I buying below conservative value, what protects that value while I wait, and who has the incentive and ability to unlock it?” Do not simply rank low P/E, P/B, or EV/EBITDA stocks. Investigate why each discount exists and whether the underlying cause is changing. 1. Investment universe and objectives * Developed markets: US, Canada, UK, Europe, Japan, Australia, and Singapore. * Market capitalization approximately US$250 million–US$35 billion; prioritize neglected small and mid caps. * Long-only, with a 3–5-year investment horizon. * Prefer identifiable catalysts within 6–24 months. * Seek a discount of at least 35–50% to conservative equity value, a base-case annualized return above 15%, and approximately 3:1 upside/downside. * Treat these as screening objectives, not reasons to manufacture favorable assumptions. * Prefer net cash or low leverage, durable cash generation, and management alignment. Do not require every candidate to be a historical high-ROIC compounder. Accept ordinary businesses when asset coverage, purchase price, governance, and the realization mechanism provide compelling protection. 2. Search creatively across these situations Situation What to investigate Potential value-unlocking mechanism Cash becoming available to shareholders Cash, securities, or cross-holdings cover a substantial portion of market capitalization, after deducting liabilities and required operating cash Executed buybacks, tender offers, special dividends, or cross-holding disposals A valuable business hidden inside a weak group One durable segment could justify most of the enterprise value while another segment obscures its economics Divestiture, closure, separation, or clearer segment disclosure Hidden assets with a credible monetization path Surplus property, listed stakes, royalties, infrastructure interests, or other separately realizable assets Signed disposal, external bid, redevelopment approval, or distribution Cash expenses approaching an end Restructuring payments, pension contributions, transition costs, or project spending temporarily suppress FCF A documented end date that releases cash without requiring revenue growth Forced selling into stable fundamentals Spin-offs, index deletions, fund liquidations, mandate restrictions, or shareholder exits create selling unrelated to operating value Seller exhaustion, independent reporting, or a new shareholder base Debt repayment changing the equity economics A sound business is directing recurring FCF toward debt reduction, reducing refinancing risk and interest expense A defined leverage target followed by capital returns Capital allocation changing after years of stagnation New leadership, board changes, incentive revisions, activist agreements, or a documented ownership transition Asset sales, reduced reinvestment in weak divisions, buybacks, or distributions A small residual business left after a major disposal Net sale proceeds explain much of market capitalization, leaving the retained business at a low implied valuation Transaction completion and a specified use of proceeds Investment spending beginning to generate returns A completed facility, installed base, distribution network, or product investment has depressed reported returns Utilization, contracted demand, or reduced growth capex improves cash generation An overcapitalized company shrinking its share count Substantial excess capital and sustained repurchases below conservative intrinsic value Executed net share reduction increases value per remaining share Temporary distress in a durable franchise A recall, customer destocking, contract reset, or operational disruption has a bounded economic cost Observable recovery milestones and removal of exceptional costs Orderly liquidation or runoff Realizable assets and distributions exceed the purchase price after all claims and wind-down expenses A credible liquidation plan, asset sales, and scheduled distributions Search beyond standard screeners. Inspect disposal announcements, tender documents, spin-off filings, segment notes, restructuring schedules, shareholder proposals, incentive plans, and buyback execution disclosures. Treat lender renewals, insider buying, and activist involvement as corroborating evidence. None independently establishes equity undervaluation or a catalyst. 3. Underwrite the margin of safety For each serious candidate, identify the principal source of protection: realizable assets, recurring earnings, distributable cash, or a combination. Calculate, where relevant: * Adjusted net cash after restricted cash, customer money, minimum operating liquidity, and other unavailable balances. * Conservative realizable asset value, with explicit haircuts, taxes, transaction costs, and timing. * Normalized owner cash flow after maintenance capex, cash interest, leases where appropriate, and recurring economic costs. * Net debt/EBITDA, debt maturities, covenant headroom, and liquidity through the catalyst window. * Operating ROIC = NOPAT / average operating invested capital, where operating invested capital = operating NWC + net PP&E. * Three- to five-year ROIIC where meaningful; flag distorted results from acquisitions, disposals, or a small or negative denominator. * Diluted share count, SBC, and actual net share reduction. Reconcile enterprise value to equity value and then to value per share. Keep cash-flow definitions consistent with the valuation numerator. Never double-count value. Examples include adding essential operating property to a going-concern valuation without charging rent, adding disposal proceeds while retaining the sold business’s earnings, or counting the same cash as both a distribution and ending cash. Show: Margin of safety = 1 − current share price / conservative intrinsic value per share. A discount to estimated value is not a guaranteed limit on drawdown. 4. Require a catalyst with an owner, an incentive, and a clock For every catalyst, answer: * What specifically happens? * Who controls the decision? * Why would they act now? * What evidence shows progress? * What approvals, financing, or counterparties are required? * How does the action create value or deliver existing value to shareholders? * How much value per share could it unlock, and when? Classify catalysts as: * Committed: approved, contracted, funded, or already executing. * Supported: concrete steps and incentives exist, but execution remains uncertain. * Speculative: primarily dependent on hope, takeover rumors, or eventual market recognition. Do not treat an unused buyback authorization, generic strategic review, possible acquisition, or “the market will recognize the value” as sufficient evidence. Distinguish catalysts that create value, distribute value, and make existing value more visible. Avoid assuming that visibility automatically closes the valuation discount. 5. Stress-test the thesis Build bear, base, and bull cases with explicit assumptions, holding periods, distributions, and terminal equity values. Also include a 24-month delay or catalyst-failure case: * Does the business generate or consume cash while waiting? * Does debt become due? * Do assets deteriorate? * Can management spend the apparent surplus? * What is the remaining value if the proposed action never happens? For operating businesses, show a flat-exit-multiple return case. For asset situations, calculate proceeds after costs, liabilities, leakage, and time. Use a reverse valuation to identify what deterioration, cash burn, asset impairment, or failure probability would justify the current price. Label inferred probabilities as model-dependent estimates. Separate returns from operating improvement, capital distributions, debt reduction, and changes in valuation. Avoid double-counting buybacks or debt repayment. 6. Reject value traps explicitly Reject or heavily penalize: * Peak-cycle earnings presented as normalized profits. * Structural decline that consumes the asset backing. * Inventory or receivables unlikely to realize book value. * Cash inaccessible to minority shareholders. * Controlling shareholders with persistent minority-unfriendly behavior. * Repeated “one-time” expenses and FCF inflated by working-capital liquidation. * Refinancing dependence before the catalyst can occur. * Asset-sale proceeds likely to fund poor acquisitions. * Unquantifiable contingent liabilities. * A thesis requiring several unrelated favorable events. For every finalist, state the strongest reason it could be a value trap. 7. Research standards and requested output Use current prices and the latest available filings. State valuation dates and financial periods. Prioritize primary filings, exchange announcements, transaction documents, and company disclosures. Separate Fact / Management claim / Inference / Estimate / Unknown. Cite material figures and catalyst evidence. Do not invent missing data or imply an exhaustive screen without the necessary coverage. First identify up to 12 credible candidates across several situations. Then select the strongest five for deeper research. Return fewer if the evidence is weak. Provide: 1. A ranked table showing business, ticker, market cap, net cash/debt, valuation basis, conservative value per share, margin of safety, catalyst, timing, base-case IRR, bear-case downside, and principal risk. 2. A concise assessment of each finalist explaining why it is cheap, what protects value, why the discount could close, and what evidence supports that conclusion. 3. Three rejected apparent bargains and the specific flaw in each. 4. The most important unresolved diligence question and a measurable thesis-kill condition for every finalist. Rank downside resilience and catalyst credibility ahead of headline upside. Keep speculative situations on a separate watchlist. Finish by answering: “Which three deserve immediate research, and which would still be attractive if their catalysts were delayed by two years?”